Recent Finacing
Recent Raise
C2i Genomics provides a cloud-based, genome-wide liquid biopsy platform using personalized tumor mutation fingerprints and ML inference to quantify circulating tumor DNA for minimal residual disease detection.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
